(BUSINESS WIRE)-- Takeda Pharmaceutical Company Limited (TOKYO:4502):
|
Strong first quarter results and confidence in Management Guidance |
•
|
|
Underlying revenue grew +9.1%, driven by a +15.3% increase of Takeda's Growth Drivers (GI, Oncology, CNS and Emerging Markets). (Reported revenue declined -2.8% to 434. ...
Source : http://me-newswire.net//news/18412/en...
Pour toute information, contactez-nous au : +(235) 99267667 ; 62883277 ; 66267667 (Bureau N'Djamena)
|
|